...
首页> 外文期刊>AIDS >Archived HIV-1 minority variants detected by ultra-deep pyrosequencing in provirus may be fully replication competent.
【24h】

Archived HIV-1 minority variants detected by ultra-deep pyrosequencing in provirus may be fully replication competent.

机译:在原病毒中通过超深度焦磷酸测序检测到的已存档HIV-1少数变异株可能具有完全复制能力。

获取原文
获取原文并翻译 | 示例
           

摘要

In a recent study, Archer et al. [1] described a protocol enabling a fast and accurate handling of large data sets obtained by massively parallel pyrosequencing for genotypic prediction of HIV-1 coreceptor usage. This algorithm was used to study the virus present in one patient undergoing short-term treatment with a chemo-kine (C-C motif) receptor 5 (CCR-5) inhibitor, in which a phenotypic standard test [2] (Trofile; Monogram Biosciences, South San Francisco, California, USA) highlighted the presence of chemokine (CXC motif) receptor 4 (CXCR-4) using virus under therapy. The results show that the frequency of a CXCR4-using (X4) minority variant population, representing 0.5% of the initial virus quasispecies, became the predominant subpopulation, reaching 81% at day 11. Phylogenetic analysis showed that these variants did not evolve de novo as a result of drug pressure acting directly on CCR5-using (R5) virus, but they emerged from preexisting CXCR4-using variants.
机译:在最近的一项研究中,Archer等人。 [1]描述了一种协议,该协议能够快速,准确地处理通过大规模并行焦磷酸测序获得的大数据集,以用于HIV-1共受体使用的基因型预测。该算法用于研究一名接受化学因子(CC基序)受体5(CCR-5)抑制剂短期治疗的患者中存在的病毒,其中采用了表型标准测试[2](Trofile; Monogram Biosciences,美国加利福尼亚州南旧金山市)强调指出,使用正在治疗的病毒,存在趋化因子(CXC基序)受体4(CXCR-4)。结果表明,使用CXCR4的少数(X4)变异群体占原始病毒准种的0.5%,成为主要的亚群,在第11天时达到81%。系统发育分析表明,这些变异没有重新进化由于药物压力直接作用于使用CCR5的(R5)病毒,但它们是从预先存在的使用CXCR4的变体中出现的。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号